| Product revenue | 0 |
| Research and development contract revenue | 0 |
| Total revenue | 0 |
| Research and development | 355.86K |
| Selling, general and administrative | 718.46K |
| Restructuring | 0 |
| Depreciation and amortization | 265.3K |
| Total costs and expenses | 1.34M |
| Other income (expense) | |
| Interest expense | -119.3K |
| Amortization of note discount and financing costs | -28.27K |
| Gain on derivative liabilities | 0 |
| Loss on extinguishment of debt | 0 |
| Total other income (expense) | -147.57K |
| Net Loss | -1.49M |
| Weighted Average Common Shares Outstanding (Basic And Diluted) | |
| Net Loss Per Share (Basic and Diluted) | -0.88 |